Results from a Phase-II Clinical Trial of Baricitinib Baricitinib works by interfering with signaling pathways inside immune cells, to reduce inflammation and lower the immune system.  It is par...

My blog on good, but early, results from a JAK inhibitor as a treatment for type 1 diabetes.

cureresearch4type1diabetes.blogspot.com/2025/09/resu...
#t1d #t1dresearch #barcitinib